Ibere Pharmaceuticals (IBER) is a Blank Checks company listed on NYSE. There were no new wire items for IBER in the last 30 days. The most recent was published Mar 13, 2023.
Latest news
25 items- SECSEC Form 15-12G filed by Ibere Pharmaceuticals15-12G - IBERE PHARMACEUTICALS (0001835205) (Filer)
- SECSEC Form 25-NSE filed by Ibere Pharmaceuticals25-NSE - IBERE PHARMACEUTICALS (0001835205) (Subject)
- SECIbere Pharmaceuticals filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - IBERE PHARMACEUTICALS (0001835205) (Filer)
- NEWSIbere Pharmaceuticals Will Redeem All Outstanding Ordinary Shares Included In Units Issued In IPO Effective As Of Close Of Business On March 2; Per-Share Redemption Price For Public Shares Will Be ~$10.17; Expects That NYSE Will File Form 25 To Delist Co
- 13D/GSEC Form SC 13G filed by Ibere PharmaceuticalsSC 13G - IBERE PHARMACEUTICALS (0001835205) (Subject)
- 13D/GSEC Form SC 13G/A filed by Ibere Pharmaceuticals (Amendment)SC 13G/A - IBERE PHARMACEUTICALS (0001835205) (Subject)
- 13D/GSEC Form SC 13G filed by Ibere PharmaceuticalsSC 13G - IBERE PHARMACEUTICALS (0001835205) (Subject)
- 13D/GSEC Form SC 13G/A filed by Ibere Pharmaceuticals (Amendment)SC 13G/A - IBERE PHARMACEUTICALS (0001835205) (Subject)
- 13D/GSEC Form SC 13G/A filed by Ibere Pharmaceuticals (Amendment)SC 13G/A - IBERE PHARMACEUTICALS (0001835205) (Subject)
- SECSEC Form 10-Q filed by Ibere Pharmaceuticals10-Q - IBERE PHARMACEUTICALS (0001835205) (Filer)
- SECSEC Form 10-Q filed by Ibere Pharmaceuticals10-Q - IBERE PHARMACEUTICALS (0001835205) (Filer)
- SECSEC Form 10-Q filed by Ibere Pharmaceuticals10-Q - IBERE PHARMACEUTICALS (0001835205) (Filer)
- SECSEC Form 10-K filed by Ibere Pharmaceuticals10-K - IBERE PHARMACEUTICALS (0001835205) (Filer)
- 13D/GSEC Form SC 13G/A filed by Ibere Pharmaceuticals (Amendment)SC 13G/A - IBERE PHARMACEUTICALS (0001835205) (Subject)
- 13D/GSEC Form SC 13G filed by Ibere PharmaceuticalsSC 13G - IBERE PHARMACEUTICALS (0001835205) (Subject)
- 13D/GSEC Form SC 13G filed by Ibere PharmaceuticalsSC 13G - IBERE PHARMACEUTICALS (0001835205) (Subject)
- SECSEC Form 10-Q filed by Ibere Pharmaceuticals10-Q - IBERE PHARMACEUTICALS (0001835205) (Filer)
- 13D/GSEC Form SC 13G filed by Ibere PharmaceuticalsSC 13G - IBERE PHARMACEUTICALS (0001835205) (Subject)
- SECSEC Form 10-Q/A filed by Ibere Pharmaceuticals (Amendment)10-Q/A - IBERE PHARMACEUTICALS (0001835205) (Filer)
- SECSEC Form 10-Q filed by Ibere Pharmaceuticals10-Q - IBERE PHARMACEUTICALS (0001835205) (Filer)
- SECSEC Form 8-K/A filed by Ibere Pharmaceuticals (Amendment)8-K/A - IBERE PHARMACEUTICALS (0001835205) (Filer)
- SECIbere Pharmaceuticals filed SEC Form 8-K: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review8-K - IBERE PHARMACEUTICALS (0001835205) (Filer)
- SECIbere Pharmaceuticals filed SEC Form 8-K: Changes in Registrant’s Certifying Accountant, Financial Statements and Exhibits8-K - IBERE PHARMACEUTICALS (0001835205) (Filer)
- SECSEC Form 10-Q filed by Ibere Pharmaceuticals10-Q - IBERE PHARMACEUTICALS (0001835205) (Filer)
- PRIbere Pharmaceuticals Receives Expected NYSE Notice Regarding Delayed Quarterly ReportPHILADELPHIA, May 28, 2021 /PRNewswire/ -- Ibere Pharmaceuticals (NYSE:IBER) (the "Company") today announced that it received a notice on May 25, 2021 from the New York Stock Exchange (the "NYSE") indicating that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2021 (the "Quarterly Report") with the Securities and Exchange Commission (the "SEC"). The notice has no immediate effect on the listing of the Company's stock on the NYSE. As disclosed in the Company's Form 12b-25 filed with the SEC on May 18, 2021, on April 12, 2021 the Staff of the SEC re
IBER FAQ
7 questionsWhat does Ibere Pharmaceuticals do?
Ibere Pharmaceuticals focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in Philadelphia, Pennsylvania.What is the latest news on IBER?
Quantisnow has not tracked any new filings, ratings or press releases for IBER in the last 30 days. The most recent wire item was published on March 13, 2023.Where does IBER stock trade?
Ibere Pharmaceuticals (IBER) is listed on NYSE.What sector and industry is IBER in?
Ibere Pharmaceuticals operates in the Finance sector, Blank Checks industry.When did Ibere Pharmaceuticals go public?
Ibere Pharmaceuticals (IBER) completed its IPO in 2021.What companies are similar to IBER?
Notable peers in the same industry include PRE (Prenetics Global Limited), OXSQ (Oxford Square Capital Corp.), INV (Innventure Inc.), ILLU (Illumination Acquisition Corp I), TACO (Berto Acquisition Corp.). Compare IBER side-by-side with any of them on Quantisnow.How can I track IBER on Quantisnow?
Quantisnow aggregates Ibere Pharmaceuticals's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow IBER to receive live email and push alerts on every new disclosure.